🇺🇸 DIPYRONE in United States

3,252 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pain — 395 reports (12.15%)
  2. Vomiting — 389 reports (11.96%)
  3. Nausea — 384 reports (11.81%)
  4. Pyrexia — 324 reports (9.96%)
  5. Off Label Use — 312 reports (9.59%)
  6. Dyspnoea — 302 reports (9.29%)
  7. Headache — 299 reports (9.19%)
  8. Drug Ineffective — 293 reports (9.01%)
  9. Abdominal Pain — 280 reports (8.61%)
  10. Anaemia — 274 reports (8.43%)

Source database →

DIPYRONE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DIPYRONE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for DIPYRONE in United States?

Marketing authorisation holder not available in our data.